Advertisement
Cerus Corporation

Cerus Corporation Fundamental Analysis

CERSNASDAQ
HealthcareMedical - Devices
$2.92
$0.06(2.10%)
U.S. Market opens in 54h 42m
Advertisement

Cerus Corporation Fundamental Analysis

Cerus Corporation (CERS) shows weak financial fundamentals with a PE ratio of -56.14, profit margin of -4.29%, and ROE of -15.36%. The company generates $0.2B in annual revenue with N/A year-over-year growth of N/A.

Key Strengths

Cash Position14.19%
PEG Ratio-0.89
Current Ratio1.63

Areas of Concern

ROE-15.36%
Operating Margin-7.94%
We analyze CERS's fundamental strength across five key dimensions.

The stock receives a Fundamental Health Score of -6.0/100 based on profitability, valuation, growth, and balance sheet metrics. The F grade reflects weak fundamentals and significant financial concerns.

Fundamental Health Score

F
-6.0/100

We analyze CERS's fundamental strength across five key dimensions:

Efficiency Score

Weak

CERS struggles to generate sufficient returns from assets.

ROA > 10%
-4.28%

Valuation Score

Excellent

CERS trades at attractive valuation levels.

PE < 25
-56.14
PEG Ratio < 2
-0.89

Growth Score

Weak

CERS faces weak or negative growth trends.

Revenue Growth > 5%
N/A
EPS Growth > 10%
N/A

Financial Health Score

Moderate

CERS shows balanced financial health with some risks.

Debt/Equity < 1
1.44
Current Ratio > 1
1.63

Profitability Score

Weak

CERS struggles to sustain strong margins.

ROE > 15%
-1536.18%
Net Margin ≥ 15%
-4.29%
Positive Free Cash Flow
No

Key Financial Metrics

Is CERS Expensive or Cheap?

P/E Ratio

CERS trades at -56.14 times earnings. This suggests potential undervaluation.

-56.14

PEG Ratio

When adjusting for growth, CERS's PEG of -0.89 indicates potential undervaluation.

-0.89

Price to Book

The market values Cerus Corporation at 8.28 times its book value. This suggests the stock is fully valued or overvalued on an asset basis.

8.28

EV/EBITDA

Enterprise value stands at 426.52 times EBITDA. This signals the market has high growth expectations.

426.52

How Well Does CERS Make Money?

Net Profit Margin

For every $100 in sales, Cerus Corporation keeps $-4.29 as profit after all expenses.

-4.29%

Operating Margin

Core operations generate -7.94 in profit for every $100 in revenue, before interest and taxes.

-7.94%

ROE

Management delivers $-15.36 in profit for every $100 of shareholder equity.

-15.36%

ROA

Cerus Corporation generates $-4.28 in profit for every $100 in assets, demonstrating efficient asset deployment.

-4.28%

Following the Money - Real Cash Generation

Operating Cash Flow

Cerus Corporation generates limited operating cash flow of $2.72M, signaling weaker underlying cash strength.

$2.72M

Free Cash Flow

Cerus Corporation generates weak or negative free cash flow of $-1.26M, restricting financial flexibility.

$-1.26M

FCF Per Share

Each share generates $-0.01 in free cash annually.

$-0.01

FCF Yield

CERS converts -0.21% of its market value into free cash.

-0.21%

Financial Ratios Analysis

Valuation Ratios

P/E Ratio

Price to earnings ratio

-56.14

vs 25 benchmark

PEG Ratio

Price/earnings to growth ratio

-0.89

vs 25 benchmark

P/B Ratio

Price to book value ratio

8.28

vs 25 benchmark

P/S Ratio

Price to sales ratio

2.59

vs 25 benchmark

Financial Health

Debt/Equity

Total debt to shareholders' equity

1.44

vs 25 benchmark

Current Ratio

Current assets to current liabilities

1.63

vs 25 benchmark

Efficiency Ratios

ROE

Return on equity percentage

-0.15

vs 25 benchmark

ROA

Return on assets percentage

-0.04

vs 25 benchmark

ROCE

Return on capital employed

-0.15

vs 25 benchmark

How CERS Stacks Against Its Sector Peers

MetricCERS ValueSector AveragePerformance
P/E Ratio-56.1429.63 Better (Cheaper)
ROE-15.36%223.00% Weak
Net Margin-4.29%-38669.00% (disorted) Weak
Debt/Equity1.440.82 Weak (High Leverage)
Current Ratio1.634.30 Neutral
ROA-4.28%-379.00% (disorted) Weak

CERS outperforms its industry in 1 out of 6 key metrics, but lagging in ROE.

Historical Growth Performance

5-Year Growth Trajectory

This section reviews Cerus Corporation's 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.

Revenue CAGR

N/A

Industry Style: Defensive, Growth, Innovation

EPS CAGR

N/A

Industry Style: Defensive, Growth, Innovation

FCF CAGR

N/A

Industry Style: Defensive, Growth, Innovation

Fundamental Analysis FAQ